212 related articles for article (PubMed ID: 28912278)
1. Pituitary Macroadenoma and Visual Impairment: Postoperative Outcome Prediction with Contrast-Enhanced FIESTA.
Hisanaga S; Kakeda S; Yamamoto J; Watanabe K; Moriya J; Nagata T; Fujino Y; Kondo H; Nishizawa S; Korogi Y
AJNR Am J Neuroradiol; 2017 Nov; 38(11):2067-2072. PubMed ID: 28912278
[TBL] [Abstract][Full Text] [Related]
2. Delineation of optic nerves and chiasm in close proximity to large suprasellar tumors with contrast-enhanced FIESTA MR imaging.
Watanabe K; Kakeda S; Yamamoto J; Watanabe R; Nishimura J; Ohnari N; Nishizawa S; Korogi Y
Radiology; 2012 Sep; 264(3):852-8. PubMed ID: 22771880
[TBL] [Abstract][Full Text] [Related]
3. Splitting of the Optic Nerve by a Pituitary Macroadenoma.
Hanalioğlu Ş; Işıkay İ; Berker M
World Neurosurg; 2016 May; 89():726.e11-4. PubMed ID: 26805676
[TBL] [Abstract][Full Text] [Related]
4. Optic nerve hyperintensity on T2-weighted images among patients with pituitary macroadenoma: correlation with visual impairment.
Tokumaru AM; Sakata I; Terada H; Kosuda S; Nawashiro H; Yoshii M
AJNR Am J Neuroradiol; 2006 Feb; 27(2):250-4. PubMed ID: 16484385
[TBL] [Abstract][Full Text] [Related]
5. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression.
Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B
World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Tumor-Related Edema of Optic Tract Affecting Visual Function in Patients with Sellar and Suprasellar Tumors.
Ju DG; Jeon C; Kim KH; Park KA; Hong SD; Seoul HJ; Shin HJ; Nam DH; Lee JI; Kong DS
World Neurosurg; 2019 Dec; 132():e862-e868. PubMed ID: 31394363
[TBL] [Abstract][Full Text] [Related]
7. Analysis of visual field disturbance in patients with sellar and suprasellar lesions: relationship with magnetic resonance imaging findings and sagittal bending of the optic nerve.
Yamaguchi R; Tosaka M; Shinohara Y; Todokoro D; Mukada N; Miyagishima T; Akiyama H; Yoshimoto Y
Acta Neurol Belg; 2022 Aug; 122(4):1031-1041. PubMed ID: 35716312
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting the Visual Outcome of Pituitary Adenoma Patients Treated with Endoscopic Transsphenoidal Surgery.
Luomaranta T; Raappana A; Saarela V; Liinamaa MJ
World Neurosurg; 2017 Sep; 105():422-431. PubMed ID: 28583452
[TBL] [Abstract][Full Text] [Related]
9. An Analysis of Retinal Nerve Fiber Layer Thickness before and after Pituitary Adenoma Surgery and its Correlation with Visual Acuity.
Iqbal M; Irfan S; Goyal JL; Singh D; Singh H; Dutta G
Neurol India; 2020; 68(2):346-351. PubMed ID: 32189695
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions.
Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H
J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700
[TBL] [Abstract][Full Text] [Related]
11. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.
Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW
Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587
[TBL] [Abstract][Full Text] [Related]
13. Surgical results of large and giant pituitary adenomas with special consideration of ophthalmologic outcomes.
Müslüman AM; Cansever T; Yılmaz A; Kanat A; Oba E; Çavuşoğlu H; Sirinoğlu D; Aydın Y
World Neurosurg; 2011; 76(1-2):141-8; discussion 63-6. PubMed ID: 21839965
[TBL] [Abstract][Full Text] [Related]
14. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
[TBL] [Abstract][Full Text] [Related]
15. Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968-1987.
Sullivan LJ; O'Day J; McNeill P
J Clin Neuroophthalmol; 1991 Dec; 11(4):262-7. PubMed ID: 1838546
[TBL] [Abstract][Full Text] [Related]
16. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.
Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM
Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885
[TBL] [Abstract][Full Text] [Related]
17. Significance and Indications of Surgery for Asymptomatic Nonfunctioning Pituitary Adenomas.
Ogiwara T; Nagm A; Nakamura T; Mbadugha T; Horiuchi T; Hongo K
World Neurosurg; 2019 Aug; 128():e752-e759. PubMed ID: 31077893
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography predicts visual outcome for pituitary tumors.
Danesh-Meyer HV; Wong A; Papchenko T; Matheos K; Stylli S; Nichols A; Frampton C; Daniell M; Savino PJ; Kaye AH
J Clin Neurosci; 2015 Jul; 22(7):1098-104. PubMed ID: 25891894
[TBL] [Abstract][Full Text] [Related]
19. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
Hajiabadi M; Alimohamadi M; Fahlbusch R
World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
[TBL] [Abstract][Full Text] [Related]
20. The time course of visual field recovery following transphenoidal surgery for pituitary adenomas: predictive factors for a good outcome.
Gnanalingham KK; Bhattacharjee S; Pennington R; Ng J; Mendoza N
J Neurol Neurosurg Psychiatry; 2005 Mar; 76(3):415-9. PubMed ID: 15716538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
